UBS Group’s LAVA Therapeutics LVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.6K | Sell |
16,380
-515
| -3% | -$680 | ﹤0.01% | 7067 |
|
|
2025
Q1 | $21.5K | Sell |
16,895
-1,536
| -8% | -$1.95K | ﹤0.01% | 6885 |
|
|
2024
Q4 | $17.5K | Buy |
18,431
+17,359
| +1,619% | +$16.5K | ﹤0.01% | 6734 |
|
|
2024
Q3 | $1.78K | Buy |
+1,072
| New | +$1.78K | ﹤0.01% | 7340 |
|
|
2024
Q2 | – | Sell |
-8,980
| Closed | -$29.9K | – | 8595 |
|
|
2024
Q1 | $29.9K | Buy |
+8,980
| New | +$29.9K | ﹤0.01% | 5575 |
|
|
2023
Q2 | – | Sell |
-4,095
| Closed | -$6.8K | – | 8162 |
|
|
2023
Q1 | $6.8K | Buy |
4,095
+3,094
| +309% | +$5.14K | ﹤0.01% | 6785 |
|
|
2022
Q4 | $3.5K | Buy |
+1,001
| New | +$3.5K | ﹤0.01% | 8302 |
|
|
2022
Q3 | – | Sell |
-406
| Closed | -$1K | – | 9488 |
|
|
2022
Q2 | $1K | Sell |
406
-820
| -67% | -$2.02K | ﹤0.01% | 8858 |
|
|
2022
Q1 | $5K | Sell |
1,226
-523
| -30% | -$2.13K | ﹤0.01% | 8083 |
|
|
2021
Q4 | $10K | Buy |
+1,749
| New | +$10K | ﹤0.01% | 7663 |
|